We are live on ! Find out more
GMED icon

Globus Medical

191 hedge funds and large institutions have $1.85B invested in Globus Medical in 2015 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 59 increasing their positions, 70 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,696% more call options, than puts

Call options by funds: $2.46M | Put options by funds: $137K

35% more capital invested

Capital invested by funds: $1.37B → $1.85B (+$479M)

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

5% more funds holding

Funds holding: 182191 (+9)

0.13% more ownership

Funds ownership: 93.82%93.95% (+0.13%)

16% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 70

Holders
191
Holders Change
+9
Holders Change %
+4.95%
% of All Funds
5.01%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
38
Increased
59
Reduced
70
Closed
29
Calls
$2.46M
Puts
$137K
Net Calls
+$2.32M
Net Calls Change
+$2.79M
Name Holding Trade Value Shares
Change
Change in
Stake
Envestnet Asset Management
126
Envestnet Asset Management
Illinois
$682K +$101K +4,013 +20%
Citigroup
127
Citigroup
New York
$680K +$512K +20,408 +504%
CB
128
Commerce Bank
Missouri
$670K -$753 -30 -0.1%
ONB
129
Old National Bancorp
Indiana
$630K -$3.44K -137 -0.6%
HighTower Advisors
130
HighTower Advisors
Illinois
$624K +$50.8K +2,022 +10%
State Board of Administration of Florida Retirement System
131
State Board of Administration of Florida Retirement System
Florida
$618K +$44.8K +1,786 +9%
AA
132
ALPS Advisors
Colorado
$577K
TI
133
Trexquant Investment
Connecticut
$568K +$512K +20,400 New
MCM
134
Mazama Capital Management
Oregon
$523K +$472K +18,783 New
MC
135
Menta Capital
California
$502K +$453K +18,042 New
SB
136
Suntrust Banks
Georgia
$487K +$440K +17,530 New
GS
137
GAM Systematic
United Kingdom
$483K -$892K -35,520 -67%
BNP Paribas Financial Markets
138
BNP Paribas Financial Markets
France
$439K +$36.2K +1,443 +10%
Principal Financial Group
139
Principal Financial Group
Iowa
$393K -$31.2K -1,242 -8%
SJIM
140
St. Johns Investment Management
Florida
$385K
OAM
141
Oberweis Asset Management
Illinois
$380K +$343K +13,661 New
Legal & General Group
142
Legal & General Group
United Kingdom
$378K +$21.3K +850 +7%
T. Rowe Price Associates
143
T. Rowe Price Associates
Maryland
$369K +$77.3K +3,080 +30%
RG
144
Renaissance Group
Kentucky
$362K -$6.88K -274 -2%
PAG
145
Private Advisor Group
New Jersey
$348K -$111K -4,441 -26%
PP
146
Paloma Partners
Connecticut
$328K +$50.1K +1,997 +20%
PCM
147
Penserra Capital Management
California
$308K +$278K +11,084 New
Barclays
148
Barclays
United Kingdom
$292K -$75.3K -2,999 -22%
Arrowstreet Capital
149
Arrowstreet Capital
Massachusetts
$278K -$2.82M -112,300 -92%
ProShare Advisors
150
ProShare Advisors
Maryland
$278K +$251K +9,991 New

GMED Hedge Fund Activity: Q4 2015 in Review

191 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2015, worth a combined $1.85B — up 35% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new GMED positions and 29 closed out — a net gain of 9 holders — while 59 added to existing stakes and 70 trimmed.

The largest buyer was Select Equity Group, opening a new position worth an estimated $38.4M. The largest seller was Marshall Wace, exiting entirely with an estimated $12.4M sold.

  • 191 institutional investors held Globus Medical (GMED) as of Q4 2015, up from 182 in Q3 2015.
  • Funds reported $1.85B of Globus Medical stock for Q4 2015, up 35% quarter-over-quarter.
  • 38 funds opened new Globus Medical positions in Q4 2015 and 29 closed out, a net change of +9 holders.
  • The largest Globus Medical buyer in Q4 2015 was Select Equity Group, an estimated $38.4M added.
  • The largest Globus Medical seller in Q4 2015 was Marshall Wace, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2015.